# US 2019/0099519 A1 · Method for producing nanosurfaces with nano, micron, and/or submicron structures on a polymer

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0099519 A1
- Document ID: US20190099519A1
- Status: Published application
- Kind: A1
- Application number: 16/146,566
- Filed: 2018-09-28
- Published: 2019-04-04
- Earliest claimed: 2010-06-25
- Assignees: Nanovis, LLC
- Applicants: Nanovis, Inc.
- Inventors: Matthew HEDRICK; Ganesan BALASUNDARAM; Chang YAO
- Web page: https://patentgrep.com/patent/US20190099519A1

## CPC

- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61B 17/0401: {Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors (A61B17/0642 takes precedence; fixation devices for tendons or ligaments A61F2/0811)}
- A61B 17/06166: {Sutures (suture materials A61L17/00; manufacture of artificial threads D01D; treatment of threads D06M)}
- A61C 8/00: Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools (fastening of peg-teeth in the mouth A61C13/30)
- A61F 2/0063: {Implantable repair or support meshes, e.g. hernia meshes}
- A61L 17/04: Non-resorbable materials
- A61L 17/14: Post-treatment to improve physical properties
- A61L 27/10: Ceramics or glasses
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 31/048: {obtained by reactions only involving carbon-to-carbon unsaturated bonds (A61L31/041 takes precedence)}
- A61L 31/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)}
- A61L 31/14: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- B29C 59/022: {characterised by the disposition or the configuration, e.g. dimensions, of the embossments or the shaping tools therefor}
- C08F 110/06: Propene
- C08G 63/88: Post-polymerisation treatment
- C08G 65/4012: {Other compound (II) containing a ketone group, e.g. X-Ar-C(=O)-Ar-X for polyetherketones}
- C08G 65/46: Post-polymerisation treatment, e.g. recovery, purification, drying
- C08L 23/10: Homopolymers or copolymers of propene
- C08L 71/00: Compositions of polyethers obtained by reactions forming an ether link in the main chain (of polyacetals C08L59/00; of epoxy resins C08L63/00; of polythioether-ethers C08L81/02; of polyether-sulfones C08L81/06); Compositions of derivatives of such polymers
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- A61L 2400/18: Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
- B29C 41/24: for making articles of indefinite length
- B29K 2071/00: Use of polyethers {, e.g. PEEK, i.e. polyether-etherketone or PEK, i.e. polyetherketone or derivatives thereof}, as moulding material
- B29L 2031/7532: {Artificial members, protheses}
- C08G 2650/40: containing ketone groups, e.g. polyarylethylketones, PEEK or PEK
- Y10T 428/24355: Continuous and nonuniform or irregular surface on layer or component [e.g., roofing, etc.]
- Y10T 428/2978: Surface characteristic
- Y10T 428/2982: Particulate matter [e.g., sphere, flake, etc.]
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61C: DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE (non-driven toothbrushes A46B; {tongue scrapers A61B17/24;} preparations for dentistry A61K6/00; preparations for cleaning the teeth or mouth A61K8/00, A61Q11/00)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- B29C: SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING (making preforms B29B11/00; making laminated products by combining previously unconnected layers which become one product whose layers will remain together B32B37/00 - B32B41/00)
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)
- B29K: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR {MOULDS, } REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29L: INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The present invention relates to a modified polymeric material. The modified polymeric material includes a polymer having a modified surface, where the modified surface includes nano, micron, and/or submicron scale features. The present invention also relates to an implant comprising the modified polymeric material. The present invention further relates to processes for making the modified polymeric material and the implant.

## Claims

### Claim 1

A modified polymeric material comprising a polymer having a modified surface, wherein said modified surface comprises nano, micron, and/or submicron scale features.

### Claim 2 (depends on 1)

The modified polymeric material according to claim 1, wherein the polymer is a thermoplastic polymer.

### Claim 3 (depends on 2)

The modified polymeric material according to claim 2, wherein the thermoplastic polymer is selected from the group consisting of polypropylene, polyetheretherketone (PEEK), poly lactic glycolic acid, poly lactic lactic acid, poly lactic acid, polyurethane, and the like.

### Claim 4 (depends on 1)

The modified polymeric material according to claim 1, wherein the polymer is in the form of a polymeric film, fiber, sphere, ovoid, rod, filament, monofilament, or scaffold, plug, or matrix.

### Claim 5 (depends on 1)

The modified polymeric material according to claim 1, wherein said modified polymeric material is effective to modify biological response (e.g., increased or decreased tissue or bacteria attachment), fixation (e.g., improve mechanical interface with bone), or therapeutic attachment/delivery compared to a corresponding non-modified polymeric material.

### Claim 6 (depends on 5)

The modified polymeric material according to claim 5, wherein the biological response is selected from the group consisting of protein or antibody adsorption, cell attachment, cell function, and tissue growth.

### Claim 7 (depends on 5)

The modified polymeric material according to claim 5, wherein the therapeutic is selected from the group consisting of a peptide, protein, growth factor, antibody, drug, metal, antimicrobial metal, biologic tissue, biologic agent, chemical agent, stem cell, modified cell, and the like.

### Claim 8 (depends on 1)

The modified polymeric material according to claim 1 further comprising:
a functional attachment effective to increase biological response or therapeutic attachment/delivery; and/or
a ceramic, metal, or another polymer integrated into the modified polymeric material or coated onto the surface of the modified polymeric material.

### Claim 9 (depends on 8)

The modified polymeric material according to claim 8, wherein the functional attachment is selected from the group consisting of a peptide, protein, growth factor, antibody, drug, metal, antimicrobial metal, biologic tissue, biologic agent, chemical agent, stem cell, modified cell, and the like.

### Claim 10 (depends on 1)

An implant comprising:
a modified polymeric material according to claim 1.

### Claim 11 (depends on 10)

The implant according to claim 10, wherein the polymer is polypropylene and the implant is a hernia mesh or polymer suture.

### Claim 12 (depends on 10)

The implant according to claim 10, wherein the polymer is PEEK and the implant is a spine cage, vertebral body replacement, suture anchor, dental implant, maxillofacial implant, or the like.

### Claim 13

A process for preparing a modified polymeric material, said process comprising:
providing a polymer; and
subjecting the polymer to a high vacuum treatment regimen under conditions effective to modify the surface of the polymer by introducing nano, micron, and/or submicron scale features to the surface of the polymer.

### Claim 14 (depends on 13)

The process according to claim 13, wherein the high vacuum treatment regimen comprises:
heating the polymer at a high temperature; and/or
incubating the heat-treated polymer in a vacuum chamber under high vacuum conditions effective to modify the surface of the polymer,
wherein said heating can be at a heat range specific to the polymer and relative to the polymer's melting and crystallization temperature.

### Claim 15 (depends on 14)

The process according to claim 14, wherein said heating is carried out at a temperature of between about 300° C. and about 400° C.

### Claim 16 (depends on 14)

The process according to claim 14, wherein said heating is carried out at a temperature of about 350° C. for between about 1 and about 90 minutes.

### Claim 17 (depends on 13)

The process according to claim 13, wherein said incubating is carried out for at least 5 hours.

### Claim 18 (depends on 13)

The process according to claim 13, wherein the high vacuum treatment regimen comprises:
subjecting the polymer to heating and simultaneous high vacuum conditions effective to modify the surface of the polymer.

### Claim 19 (depends on 18)

The process according to claim 18, wherein said subjecting comprises:
(a) loading the polymer at a temperature of about 150° C.;
(b) applying high vacuum conditions of about 10 mTorr;
(c) increasing the temperature to about 350° C. over the course of about 1 hour;
(d) maintaining the polymer at about 350° C. at 10 mTorr for about 1 hour;
(e) decreasing the temperature to about 150° C. over the course of about 1 hour; and
(f) extracting the polymer at about 150° C.

### Claim 20 (depends on 19)

The process according to claim 19 further comprising:
storing the extracted polymer under high vacuum conditions for about 8 hours.

### Claim 21

A process for preparing a modified polymeric material, said process comprising:
providing a polymer; and
incubating the polymer in mild heat in a vacuum chamber under high vacuum conditions effective to modify the surface of the polymer by introducing nano, micron, and/or submicron scale features to the surface of the polymer.

### Claim 22 (depends on 21)

The process according to claim 21, wherein said mild heat comprises a temperature of not more than 70° C.

### Claim 23 (depends on 21)

The process according to claim 21, wherein said incubating is carried out for between about 18 and 30 hours.

### Claim 24

A process for preparing a modified polymeric material, said process comprising:
providing a polymer; and
incubating the polymer in methylene chloride in a vacuum chamber under high vacuum conditions effective to modify the surface of the polymer by introducing micron and/or submicron scale features to the surface of the polymer.

### Claim 25 (depends on 24)

The process according to claim 24, wherein said incubating is carried out for between about 18 and 30 hours.

### Claim 26 (depends on 13)

The process according to claim 13 further comprising:
applying an acid etching procedure either before or after the polymer is modified; and/or
integrating/coating the modified polymeric material with hydroxyapatite, titanium, calcium phosphate, and/or the like to yield a two layer or integration of the modified polymeric material and the hydroxyapatite, titanium, calcium phosphate, and the like.

### Claim 27 (depends on 13)

The process according to claim 13, wherein the polymer is a thermoplastic polymer.

### Claim 28 (depends on 27)

The process according to claim 27, wherein the thermoplastic polymer is selected from the group consisting of polypropylene, polyetheretherketone (PEEK), poly lactic glycolic acid, poly lactic lactic acid, poly lactic acid, polyurethane, and the like.

### Claim 29 (depends on 13)

The process according to claim 13, wherein the polymer is in the form of a polymeric film, fiber, sphere, ovoid, rod, filament, monofilament, or scaffold, plug, or matrix.

### Claim 30 (depends on 13)

The process according to claim 13, wherein said modified polymeric material is effective to modify biological response (e.g., increased or decreased tissue or bacteria attachment), fixation (e.g., improve mechanical interface with bone), or therapeutic attachment/delivery compared to a corresponding non-modified polymeric material.

### Claim 31 (depends on 30)

The process according to claim 30, wherein the biological response is selected from the group consisting of protein or antibody adsorption, cell attachment, cell function, and tissue growth.

### Claim 32 (depends on 30)

The process according to claim 30, wherein the therapeutic is selected from the group consisting of a peptide, protein, growth factor, antibody, drug, metal, antimicrobial metal, biologic tissue, biologic agent, chemical agent, stem cell, modified cell, and the like.

### Claim 33 (depends on 13)

The process according to claim 13 further comprising:
a functional attachment effective to increase biological response or therapeutic attachment/delivery; and/or
a ceramic, metal, or another polymer integrated into the modified polymeric material or coated onto the surface of the modified polymeric material.

### Claim 34 (depends on 33)

The process according to claim 33, wherein the functional attachment is selected from the group consisting of a peptide, protein, growth factor, antibody, drug, metal, antimicrobial metal, biologic tissue, biologic agent, chemical agent, stem cell, modified cell, and the like.

### Claim 35 (depends on 13)

A modified polymeric material produced by the process according to claim 13.

### Claim 36 (depends on 35)

A modified polymeric material according to claim 35, wherein said modified polymeric material can be used as, used with, or combined with biomaterials (e.g., scaffolds, bone void fillers, fusion materials autograft, Demineralized bone graft, allograft, xenograft, and the like), components, local and systemic drug delivery materials/polymers, and various other items suitable for being used or combined with the modified polymeric material.

### Claim 37 (depends on 35)

A modified polymeric material according to claim 35, wherein said modified polymeric material further includes two layer/integration aspects (e.g., integrating/coating with hydroxyapatite, titanium, calcium phosphate).

### Claim 38 (depends on 13)

An implant comprising a modified polymeric material produced according to the process of claim 13.
